Cutaneous T Cell Lymphoma

Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin lymphoma, primarily affecting the skin. It arises from malignant T-cells, a type of white blood cell, leading to the formation of skin lesions. Research in CTCL focuses on understanding its pathogenesis, developing targeted therapies, and improving patient outcomes. Recent advancements include the identification of genetic mutations driving CTCL progression and the development of novel immunotherapies and targeted drugs such as monoclonal antibodies and immune checkpoint inhibitors. Additionally, studies exploring the tumor microenvironment and the role of immune cells in CTCL aim to uncover new treatment strategies. Collaborative efforts between researchers and clinicians continue to drive progress in unraveling the complexities of CTCL and devising more effective therapies for patients.